Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up

Autor: Dezellus, A., Mirallie, S., Leperlier, F., Sauterey, B., Bouet, P.-E., Dessaint, A., Duros, S., Gremeau, A.S., Mouret-Reynier, M.-A., Durand, L.M., Venat, L., De Blay, P., Robert, M., Freour, T., Campone, M., Blanc-Lapierre, A., Bordes, V.
Zdroj: In The Breast October 2024 77
Databáze: ScienceDirect
Externí odkaz: